GHRL and colorectal carcinoma: Among patients with higher BMI and CRC, the survival benefit in higher BMI patients might be related to better nutritional status, more optimized drug therapy, more prominent endothelial progenitor cells, lower thromboxane production, higher ghrelin sensitivity and lower TNF-α [33].